These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 29168398

  • 21. Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis.
    Castañé H, Jiménez-Franco A, Martínez-Navidad C, Placed-Gallego C, Cambra-Cortés V, Perta AM, París M, Castillo DD, Arenas M, Camps J, Joven J.
    Antioxidants (Basel); 2023 Nov 23; 12(12):. PubMed ID: 38136158
    [Abstract] [Full Text] [Related]

  • 22. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A, Gur M, Demirbag R, Yilmaz R, Akyol S, Aslan M, Erel O.
    Clin Biochem; 2008 Jul 23; 41(10-11):779-84. PubMed ID: 18355454
    [Abstract] [Full Text] [Related]

  • 23. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
    Saeed SA, Elsharkawy M, Elsaeed K, Fooda O.
    Hemodial Int; 2008 Oct 23; 12(4):471-9. PubMed ID: 19090870
    [Abstract] [Full Text] [Related]

  • 24. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
    Krzystek-Korpacka M, Patryn E, Hotowy K, Czapińska E, Majda J, Kustrzeba-Wójcicka I, Noczyńska A, Gamian A.
    Adv Clin Exp Med; 2013 Oct 23; 22(2):229-36. PubMed ID: 23709379
    [Abstract] [Full Text] [Related]

  • 25. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
    Ferretti G, Bacchetti T, Masciangelo S, Bicchiega V.
    Obesity (Silver Spring); 2010 Jun 23; 18(6):1079-84. PubMed ID: 19834469
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Nomani H, Ebrahimi A, Tavilani H, Pourmotabbed T.
    Br J Dermatol; 2012 Dec 23; 167(6):1279-86. PubMed ID: 22835076
    [Abstract] [Full Text] [Related]

  • 30. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
    Kirbas A, Kirbas S, Cure MC, Tufekci A.
    J Clin Neurosci; 2014 Mar 23; 21(3):451-5. PubMed ID: 24145052
    [Abstract] [Full Text] [Related]

  • 31. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I.
    Eur J Clin Invest; 2006 Nov 23; 36(11):779-87. PubMed ID: 17032345
    [Abstract] [Full Text] [Related]

  • 32. Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
    Takci Z, Bilgili SG, Karadag AS, Kucukoglu ME, Selek S, Aslan M.
    J Eur Acad Dermatol Venereol; 2015 Feb 23; 29(2):367-370. PubMed ID: 24854673
    [Abstract] [Full Text] [Related]

  • 33. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M, Akca R, Sarandol E, Dilek K.
    J Nephrol; 2004 Feb 23; 17(6):813-8. PubMed ID: 15593056
    [Abstract] [Full Text] [Related]

  • 34. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
    Kannampuzha J, Darling PB, Maguire GF, Donnelly S, McFarlane P, Chan CT, Connelly PW.
    Clin Nephrol; 2010 Feb 23; 73(2):131-8. PubMed ID: 20129020
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata.
    Dizen-Namdar N, Emel Kocak F, Kidir M, Sarici G, Tak H, Altuntas I.
    Skin Pharmacol Physiol; 2019 Feb 23; 32(2):59-64. PubMed ID: 30544126
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.
    Mehdi MM, Rizvi SI.
    Arch Med Res; 2012 Aug 23; 43(6):438-43. PubMed ID: 22959975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.